Loading company
20/20 Biolabs, Inc.
AIDX · Nasdaq · ·
$0.42-4.4%Sep 29 close
- 1M
- -33.4%
- 6M
- -76.7%
AIDX · Nasdaq · ·
$0.42-4.4%Sep 29 close
From the company’s own 8-K filing.
Releases land after the close or before the open, so the move is the session that follows.
The quote and the company description come from 20/20 Biolabs, Inc.’s Item 2.02 8-K filed August 17, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
20/20 Biolabs, Inc. has no earnings call transcript available.